MindWalk Holdings Corp. Q1 FY2027 earnings call

• ReefIQ Platform Launch: Launched proprietary data platform ReefIQ in June 2026, designed to structure unstructured biological data for AI models. It is positioned as a substrate layer enabling deeper insights and recurring revenue relationships.
• Enterprise Adoption Strategy: Engaged with multiple large pharmaceutical companies for enterprise deployments of ReefIQ. These negotiations are at various stages but are encouraged by client resonance. Management emphasizes that these potential deals are substantially larger than historical Lens AI contracts.
• Commercial Model Shift: Transitioning from discrete project-based engagements to broader platform partnerships where MindWalk participates in the economics of created assets. Approximately 80% of the current commercial funnel by value is now structured this way.
• Infrastructure Milestone: Validated production deployment of OpenFold 3 on AMD Instinct MI325X GPUs with partner AMD and Vulture. This compute win allows for scaling ReefIQ and running more discovery programs.
• Internal Pipeline Progress: Advanced internal pipeline through preclinical development. Added experienced leadership to accelerate IND-enabling work. Ten molecules are currently in Phase I-III trials, with four being first-in-class.
• Capital Position: Announced a binding commitment for a $30 million USD unsecured revolving credit facility at a fixed 7% rate. This provides financial flexibility without equity dilution, supporting investments in ReefIQ and the internal pipeline.

Revenue for the first quarter of fiscal year 2027 was CAD $3.8 million, representing a 21% increase from CAD $3.2 million in the same period last year. This marks five consecutive quarters of year-over-year revenue growth. Gross margin expanded significantly to 59% (CAD $2.2 million) compared to 48% (CAD $1.5 million) in the prior year. The company did not break down financial performance by specific product segments (e.g., ReefIQ vs. Lens AI) within the provided transcript.

• Revenue Growth Pattern: CFO Scott indicated that initial ReefIQ agreements will likely be 'lumpy' due to their milestone-based engineering nature before converting to annual recurring revenue. Forecasting short-term revenue is difficult due to this lumpy adoption pattern.
• No Specific Financial Targets: Management declined to provide specific timelines for closing the first ReefIQ agreement or specific revenue guidance for the next 12-24 months, citing the complexity and varying stages of negotiations.
• Strategic Direction: Emphasis remains on sustained execution and delivery to reflect value in the stock over time, rather than providing short-term financial metrics.

• Negotiation Complexity: Gating factors for ReefIQ adoption include IT security/data governance reviews, legal/procurement processes for new multi-year contract shapes, and scoping of data domains. These can delay conversions.
• Revenue Lumpiness: The shift to partnership/economics-sharing models may result in unpredictable revenue recognition patterns in the near term.
• Operational Investment Costs: Increased sales, marketing, and R&D expenses are driving higher net losses ($6.1 million vs $4.1 million prior year), reflecting deliberate investment behind future opportunities rather than operational inefficiency.

Q: Charles Wallace asked what portion of Q1 revenue was contracted recurring platform revenue (ReefIQ) and when the $30M credit facility would be drawn. / A: CEO Bath clarified ReefIQ is newly launched and not yet generating significant contracted recurring revenue; existing revenue is largely from other platforms. CFO Scott stated the credit facility requires 60 days to finalize documentation, with draws occurring only as needed for liquidity, not immediately. CEO confirmed the facility does not replace the ring-fenced Cayman asset financing structures.

Q: Dania Ben-Hale asked about revenue growth expectations over the next 1-2 years and which components (ReefIQ, subscriptions, partnerships) clients are focusing on. / A: CFO noted revenue will be lumpy initially due to milestone-based ReefIQ contracts. CEO explained that while ReefIQ interest is high among large pharma for data integration, the primary driver is the shift to partnership models (back-loaded economics). Every client discussion now includes partnership terms, expanding Lens AI SaaS adoption, and ReefIQ inquiries, with partnerships being the leading conversation topic.